Naltrexone and brain scans for teens with eating disorders
Treatments studied
Part of Mental health clinical trials.
This early study tests whether naltrexone (a prescription medicine) changes brain activity measured by MRI in teens and young adults with binge eating and/or purging. It may help researchers understand how the brain works in these eating disorders and whether this treatment could be helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 13 and 21 years old
- You have an eating disorder diagnosis that involves binge eating and and/or purging
- Your medication plan must be stable—no dose or medicine changes in the last 4 weeks
- If you’re under 18, you and your parent/guardian must be willing to agree and complete study steps
- You must be able to safely get an MRI (no MRI-incompatible metal in your body)
- You must not be pregnant and must be able to do the pregnancy test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans to understand how the brain processes rewards and learns in people with anorexia nervosa or bulimia nervosa, compared with healthy adults. It may help researchers find better ways to target learning and reward problems related to these eating disorders.
This study uses brain scans to understand how people with eating disorders make decisions and learn. It may help find better treatments for anorexia and bulimia.
This trial studies the underlying brain and behavior mechanisms of anorexia nervosa or bulimia nervosa. It may help researchers understand what drives these conditions and what could be targeted in future treatments.
This study uses functional MRI to observe brain activity at rest in people with anorexia or bulimia. The goal is to learn more about how eating disorders affect the brain.
This study looks at how the brain works in teenagers with anorexia, using brain scans. The goal is to understand changes in the brain linked to eating disorders, which could help improve treatment.
This study tests whether a medication called naltrexone can help reduce the urge or behavior of self-injury (hurting yourself on purpose) in people who have not improved with standard treatment. It may offer a new option to manage these urges.
Hear when a new Eating Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.